nodes	percent_of_prediction	percent_of_DWPC	metapath
Apomorphine—HTR2B—Raloxifene—osteoporosis	0.237	1	CbGbCtD
Apomorphine—Nasopharyngitis—Pamidronate—osteoporosis	0.00263	0.00499	CcSEcCtD
Apomorphine—Angina pectoris—Risedronate—osteoporosis	0.00261	0.00494	CcSEcCtD
Apomorphine—Pain in extremity—Conjugated Estrogens—osteoporosis	0.00259	0.00491	CcSEcCtD
Apomorphine—Constipation—Ergocalciferol—osteoporosis	0.00256	0.00485	CcSEcCtD
Apomorphine—Dehydration—Zoledronate—osteoporosis	0.0025	0.00474	CcSEcCtD
Apomorphine—Sweating increased—Pamidronate—osteoporosis	0.00248	0.0047	CcSEcCtD
Apomorphine—Flushing—Raloxifene—osteoporosis	0.00244	0.00462	CcSEcCtD
Apomorphine—Asthenia—Calcium Acetate—osteoporosis	0.00243	0.00461	CcSEcCtD
Apomorphine—Dehydration—Conjugated Estrogens—osteoporosis	0.00241	0.00456	CcSEcCtD
Apomorphine—Nasopharyngitis—Zoledronate—osteoporosis	0.00241	0.00456	CcSEcCtD
Apomorphine—Pneumonia—Risedronate—osteoporosis	0.0024	0.00455	CcSEcCtD
Apomorphine—Pruritus—Calcium Acetate—osteoporosis	0.0024	0.00455	CcSEcCtD
Apomorphine—Urinary tract infection—Ethinyl Estradiol—osteoporosis	0.00238	0.00451	CcSEcCtD
Apomorphine—Mental disorder—Estropipate—osteoporosis	0.00238	0.0045	CcSEcCtD
Apomorphine—Swelling—Estradiol—osteoporosis	0.00235	0.00445	CcSEcCtD
Apomorphine—Arthralgia—Etidronic acid—osteoporosis	0.00232	0.0044	CcSEcCtD
Apomorphine—Diarrhoea—Calcium Acetate—osteoporosis	0.00232	0.0044	CcSEcCtD
Apomorphine—Urinary tract infection—Risedronate—osteoporosis	0.00232	0.0044	CcSEcCtD
Apomorphine—Back pain—Estropipate—osteoporosis	0.00228	0.00433	CcSEcCtD
Apomorphine—Pneumonia—Pamidronate—osteoporosis	0.00228	0.00432	CcSEcCtD
Apomorphine—Mental disorder—Ibandronate—osteoporosis	0.00228	0.00432	CcSEcCtD
Apomorphine—Sweating increased—Zoledronate—osteoporosis	0.00227	0.00429	CcSEcCtD
Apomorphine—Confusional state—Etidronic acid—osteoporosis	0.00225	0.00425	CcSEcCtD
Apomorphine—Dizziness—Calcium Acetate—osteoporosis	0.00224	0.00425	CcSEcCtD
Apomorphine—Urinary tract infection—Pamidronate—osteoporosis	0.00221	0.00418	CcSEcCtD
Apomorphine—Back pain—Ibandronate—osteoporosis	0.00219	0.00415	CcSEcCtD
Apomorphine—Sweating increased—Conjugated Estrogens—osteoporosis	0.00218	0.00413	CcSEcCtD
Apomorphine—Vomiting—Calcium Acetate—osteoporosis	0.00216	0.00409	CcSEcCtD
Apomorphine—Asthenia—Ergocalciferol—osteoporosis	0.00215	0.00407	CcSEcCtD
Apomorphine—Pain in extremity—Estradiol—osteoporosis	0.00207	0.00393	CcSEcCtD
Apomorphine—Disturbance in sexual arousal—Estradiol—osteoporosis	0.00206	0.0039	CcSEcCtD
Apomorphine—Syncope—Raloxifene—osteoporosis	0.00205	0.00388	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Etidronic acid—osteoporosis	0.00203	0.00384	CcSEcCtD
Apomorphine—Urinary tract infection—Zoledronate—osteoporosis	0.00202	0.00382	CcSEcCtD
Apomorphine—Nausea—Calcium Acetate—osteoporosis	0.00202	0.00382	CcSEcCtD
Apomorphine—Loss of consciousness—Raloxifene—osteoporosis	0.00201	0.00381	CcSEcCtD
Apomorphine—Arthralgia—Estropipate—osteoporosis	0.00201	0.00381	CcSEcCtD
Apomorphine—Anxiety—Estropipate—osteoporosis	0.002	0.00379	CcSEcCtD
Apomorphine—Chest pain—Alendronate—osteoporosis	0.00198	0.00375	CcSEcCtD
Apomorphine—Chest pain—Raloxifene—osteoporosis	0.00195	0.00369	CcSEcCtD
Apomorphine—Arthralgia—Raloxifene—osteoporosis	0.00195	0.00369	CcSEcCtD
Apomorphine—Chest pain—Ibandronate—osteoporosis	0.00193	0.00365	CcSEcCtD
Apomorphine—Arthralgia—Ibandronate—osteoporosis	0.00193	0.00365	CcSEcCtD
Apomorphine—Oedema—Estropipate—osteoporosis	0.00193	0.00365	CcSEcCtD
Apomorphine—Mental disorder—Ethinyl Estradiol—osteoporosis	0.00193	0.00365	CcSEcCtD
Apomorphine—Anxiety—Ibandronate—osteoporosis	0.00192	0.00364	CcSEcCtD
Apomorphine—Constipation—Etidronic acid—osteoporosis	0.0019	0.00361	CcSEcCtD
Apomorphine—Flushing—Pamidronate—osteoporosis	0.00189	0.00358	CcSEcCtD
Apomorphine—Chest pain—Calcitriol—osteoporosis	0.00189	0.00357	CcSEcCtD
Apomorphine—Anxiety—Calcitriol—osteoporosis	0.00188	0.00356	CcSEcCtD
Apomorphine—Mental disorder—Risedronate—osteoporosis	0.00188	0.00356	CcSEcCtD
Apomorphine—Nasopharyngitis—Estradiol—osteoporosis	0.00185	0.00351	CcSEcCtD
Apomorphine—Back pain—Ethinyl Estradiol—osteoporosis	0.00185	0.00351	CcSEcCtD
Apomorphine—Shock—Raloxifene—osteoporosis	0.00184	0.00348	CcSEcCtD
Apomorphine—Feeling abnormal—Etidronic acid—osteoporosis	0.00184	0.00348	CcSEcCtD
Apomorphine—Shock—Ibandronate—osteoporosis	0.00182	0.00344	CcSEcCtD
Apomorphine—Back pain—Risedronate—osteoporosis	0.00181	0.00342	CcSEcCtD
Apomorphine—Hyperhidrosis—Raloxifene—osteoporosis	0.0018	0.00342	CcSEcCtD
Apomorphine—Hyperhidrosis—Ibandronate—osteoporosis	0.00179	0.00338	CcSEcCtD
Apomorphine—Nausea—Ergocalciferol—osteoporosis	0.00178	0.00337	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Estropipate—osteoporosis	0.00176	0.00333	CcSEcCtD
Apomorphine—Sweating increased—Estradiol—osteoporosis	0.00175	0.00331	CcSEcCtD
Apomorphine—Insomnia—Estropipate—osteoporosis	0.00174	0.0033	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Alendronate—osteoporosis	0.00173	0.00327	CcSEcCtD
Apomorphine—Flushing—Zoledronate—osteoporosis	0.00173	0.00327	CcSEcCtD
Apomorphine—Back pain—Pamidronate—osteoporosis	0.00172	0.00325	CcSEcCtD
Apomorphine—Somnolence—Estropipate—osteoporosis	0.00171	0.00324	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Raloxifene—osteoporosis	0.0017	0.00322	CcSEcCtD
Apomorphine—Insomnia—Raloxifene—osteoporosis	0.00169	0.0032	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Ibandronate—osteoporosis	0.00168	0.00319	CcSEcCtD
Apomorphine—Syncope—Risedronate—osteoporosis	0.00167	0.00317	CcSEcCtD
Apomorphine—Insomnia—Ibandronate—osteoporosis	0.00167	0.00317	CcSEcCtD
Apomorphine—Fatigue—Estropipate—osteoporosis	0.00166	0.00315	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Calcitriol—osteoporosis	0.00165	0.00312	CcSEcCtD
Apomorphine—Constipation—Estropipate—osteoporosis	0.00165	0.00312	CcSEcCtD
Apomorphine—Loss of consciousness—Risedronate—osteoporosis	0.00164	0.00311	CcSEcCtD
Apomorphine—Insomnia—Calcitriol—osteoporosis	0.00164	0.0031	CcSEcCtD
Apomorphine—Mental disorder—Zoledronate—osteoporosis	0.00163	0.00309	CcSEcCtD
Apomorphine—Anxiety—Ethinyl Estradiol—osteoporosis	0.00162	0.00308	CcSEcCtD
Apomorphine—Constipation—Alendronate—osteoporosis	0.00162	0.00307	CcSEcCtD
Apomorphine—Somnolence—Calcitriol—osteoporosis	0.00161	0.00305	CcSEcCtD
Apomorphine—Pneumonia—Estradiol—osteoporosis	0.00161	0.00304	CcSEcCtD
Apomorphine—Fatigue—Ibandronate—osteoporosis	0.00159	0.00302	CcSEcCtD
Apomorphine—Syncope—Pamidronate—osteoporosis	0.00159	0.00301	CcSEcCtD
Apomorphine—Chest pain—Risedronate—osteoporosis	0.00159	0.00301	CcSEcCtD
Apomorphine—Arthralgia—Risedronate—osteoporosis	0.00159	0.00301	CcSEcCtD
Apomorphine—Anxiety—Risedronate—osteoporosis	0.00158	0.003	CcSEcCtD
Apomorphine—Constipation—Ibandronate—osteoporosis	0.00158	0.00299	CcSEcCtD
Apomorphine—Pruritus—Etidronic acid—osteoporosis	0.00158	0.00298	CcSEcCtD
Apomorphine—Mental disorder—Conjugated Estrogens—osteoporosis	0.00157	0.00297	CcSEcCtD
Apomorphine—Back pain—Zoledronate—osteoporosis	0.00157	0.00297	CcSEcCtD
Apomorphine—Feeling abnormal—Alendronate—osteoporosis	0.00156	0.00296	CcSEcCtD
Apomorphine—Oedema—Ethinyl Estradiol—osteoporosis	0.00156	0.00296	CcSEcCtD
Apomorphine—Loss of consciousness—Pamidronate—osteoporosis	0.00156	0.00295	CcSEcCtD
Apomorphine—Urinary tract infection—Estradiol—osteoporosis	0.00155	0.00294	CcSEcCtD
Apomorphine—Constipation—Calcitriol—osteoporosis	0.00155	0.00293	CcSEcCtD
Apomorphine—Diarrhoea—Etidronic acid—osteoporosis	0.00152	0.00289	CcSEcCtD
Apomorphine—Feeling abnormal—Ibandronate—osteoporosis	0.00152	0.00288	CcSEcCtD
Apomorphine—Arthralgia—Pamidronate—osteoporosis	0.00151	0.00286	CcSEcCtD
Apomorphine—Back pain—Conjugated Estrogens—osteoporosis	0.00151	0.00286	CcSEcCtD
Apomorphine—Anxiety—Pamidronate—osteoporosis	0.00151	0.00285	CcSEcCtD
Apomorphine—Shock—Risedronate—osteoporosis	0.0015	0.00284	CcSEcCtD
Apomorphine—Confusional state—Pamidronate—osteoporosis	0.00146	0.00276	CcSEcCtD
Apomorphine—Syncope—Zoledronate—osteoporosis	0.00145	0.00275	CcSEcCtD
Apomorphine—Oedema—Pamidronate—osteoporosis	0.00145	0.00274	CcSEcCtD
Apomorphine—Shock—Pamidronate—osteoporosis	0.00142	0.0027	CcSEcCtD
Apomorphine—Loss of consciousness—Zoledronate—osteoporosis	0.00142	0.0027	CcSEcCtD
Apomorphine—Vomiting—Etidronic acid—osteoporosis	0.00142	0.00268	CcSEcCtD
Apomorphine—Hyperhidrosis—Pamidronate—osteoporosis	0.0014	0.00265	CcSEcCtD
Apomorphine—Syncope—Conjugated Estrogens—osteoporosis	0.0014	0.00265	CcSEcCtD
Apomorphine—Headache—Etidronic acid—osteoporosis	0.0014	0.00264	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Risedronate—osteoporosis	0.00139	0.00263	CcSEcCtD
Apomorphine—Asthenia—Estropipate—osteoporosis	0.00138	0.00262	CcSEcCtD
Apomorphine—Arthralgia—Zoledronate—osteoporosis	0.00138	0.00261	CcSEcCtD
Apomorphine—Chest pain—Zoledronate—osteoporosis	0.00138	0.00261	CcSEcCtD
Apomorphine—Insomnia—Risedronate—osteoporosis	0.00138	0.00261	CcSEcCtD
Apomorphine—Anxiety—Zoledronate—osteoporosis	0.00137	0.0026	CcSEcCtD
Apomorphine—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.00137	0.0026	CcSEcCtD
Apomorphine—Pruritus—Estropipate—osteoporosis	0.00136	0.00258	CcSEcCtD
Apomorphine—Asthenia—Alendronate—osteoporosis	0.00136	0.00258	CcSEcCtD
Apomorphine—Dyspnoea—Risedronate—osteoporosis	0.00136	0.00257	CcSEcCtD
Apomorphine—Hypotension—Pamidronate—osteoporosis	0.00135	0.00256	CcSEcCtD
Apomorphine—Fatigue—Ethinyl Estradiol—osteoporosis	0.00135	0.00255	CcSEcCtD
Apomorphine—Pruritus—Alendronate—osteoporosis	0.00134	0.00254	CcSEcCtD
Apomorphine—Constipation—Ethinyl Estradiol—osteoporosis	0.00134	0.00253	CcSEcCtD
Apomorphine—Confusional state—Zoledronate—osteoporosis	0.00133	0.00253	CcSEcCtD
Apomorphine—Flushing—Estradiol—osteoporosis	0.00133	0.00252	CcSEcCtD
Apomorphine—Arthralgia—Conjugated Estrogens—osteoporosis	0.00133	0.00252	CcSEcCtD
Apomorphine—Chest pain—Conjugated Estrogens—osteoporosis	0.00133	0.00252	CcSEcCtD
Apomorphine—Asthenia—Ibandronate—osteoporosis	0.00133	0.00251	CcSEcCtD
Apomorphine—Anxiety—Conjugated Estrogens—osteoporosis	0.00132	0.00251	CcSEcCtD
Apomorphine—Nausea—Etidronic acid—osteoporosis	0.00132	0.00251	CcSEcCtD
Apomorphine—Oedema—Zoledronate—osteoporosis	0.00132	0.0025	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.00132	0.0025	CcSEcCtD
Apomorphine—Diarrhoea—Estropipate—osteoporosis	0.00132	0.0025	CcSEcCtD
Apomorphine—Fatigue—Risedronate—osteoporosis	0.00131	0.00249	CcSEcCtD
Apomorphine—Insomnia—Pamidronate—osteoporosis	0.00131	0.00248	CcSEcCtD
Apomorphine—Pruritus—Ibandronate—osteoporosis	0.00131	0.00248	CcSEcCtD
Apomorphine—Constipation—Risedronate—osteoporosis	0.0013	0.00247	CcSEcCtD
Apomorphine—Shock—Zoledronate—osteoporosis	0.0013	0.00246	CcSEcCtD
Apomorphine—Diarrhoea—Alendronate—osteoporosis	0.0013	0.00246	CcSEcCtD
Apomorphine—Asthenia—Calcitriol—osteoporosis	0.0013	0.00246	CcSEcCtD
Apomorphine—Dyspnoea—Pamidronate—osteoporosis	0.00129	0.00244	CcSEcCtD
Apomorphine—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.00129	0.00244	CcSEcCtD
Apomorphine—Somnolence—Pamidronate—osteoporosis	0.00129	0.00244	CcSEcCtD
Apomorphine—Pruritus—Calcitriol—osteoporosis	0.00128	0.00242	CcSEcCtD
Apomorphine—Hyperhidrosis—Zoledronate—osteoporosis	0.00128	0.00242	CcSEcCtD
Apomorphine—Diarrhoea—Raloxifene—osteoporosis	0.00128	0.00242	CcSEcCtD
Apomorphine—Dizziness—Estropipate—osteoporosis	0.00127	0.00241	CcSEcCtD
Apomorphine—Oedema—Conjugated Estrogens—osteoporosis	0.00127	0.00241	CcSEcCtD
Apomorphine—Diarrhoea—Ibandronate—osteoporosis	0.00126	0.00239	CcSEcCtD
Apomorphine—Mental disorder—Estradiol—osteoporosis	0.00126	0.00238	CcSEcCtD
Apomorphine—Dizziness—Alendronate—osteoporosis	0.00126	0.00238	CcSEcCtD
Apomorphine—Shock—Conjugated Estrogens—osteoporosis	0.00125	0.00237	CcSEcCtD
Apomorphine—Fatigue—Pamidronate—osteoporosis	0.00125	0.00236	CcSEcCtD
Apomorphine—Constipation—Pamidronate—osteoporosis	0.00124	0.00234	CcSEcCtD
Apomorphine—Diarrhoea—Calcitriol—osteoporosis	0.00124	0.00234	CcSEcCtD
Apomorphine—Hypotension—Zoledronate—osteoporosis	0.00124	0.00234	CcSEcCtD
Apomorphine—Dizziness—Raloxifene—osteoporosis	0.00123	0.00234	CcSEcCtD
Apomorphine—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.00123	0.00233	CcSEcCtD
Apomorphine—Vomiting—Estropipate—osteoporosis	0.00123	0.00232	CcSEcCtD
Apomorphine—Dizziness—Ibandronate—osteoporosis	0.00122	0.00231	CcSEcCtD
Apomorphine—Back pain—Estradiol—osteoporosis	0.00121	0.00229	CcSEcCtD
Apomorphine—Headache—Estropipate—osteoporosis	0.00121	0.00229	CcSEcCtD
Apomorphine—Vomiting—Alendronate—osteoporosis	0.00121	0.00229	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.0012	0.00228	CcSEcCtD
Apomorphine—Insomnia—Zoledronate—osteoporosis	0.0012	0.00227	CcSEcCtD
Apomorphine—Feeling abnormal—Pamidronate—osteoporosis	0.00119	0.00226	CcSEcCtD
Apomorphine—Hypotension—Conjugated Estrogens—osteoporosis	0.00119	0.00225	CcSEcCtD
Apomorphine—Headache—Alendronate—osteoporosis	0.00119	0.00225	CcSEcCtD
Apomorphine—Vomiting—Raloxifene—osteoporosis	0.00119	0.00225	CcSEcCtD
Apomorphine—Dyspnoea—Zoledronate—osteoporosis	0.00118	0.00223	CcSEcCtD
Apomorphine—Somnolence—Zoledronate—osteoporosis	0.00118	0.00223	CcSEcCtD
Apomorphine—Vomiting—Ibandronate—osteoporosis	0.00117	0.00223	CcSEcCtD
Apomorphine—Headache—Raloxifene—osteoporosis	0.00117	0.00221	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.00116	0.0022	CcSEcCtD
Apomorphine—Headache—Ibandronate—osteoporosis	0.00116	0.00219	CcSEcCtD
Apomorphine—Insomnia—Conjugated Estrogens—osteoporosis	0.00115	0.00218	CcSEcCtD
Apomorphine—Vomiting—Calcitriol—osteoporosis	0.00115	0.00218	CcSEcCtD
Apomorphine—Nausea—Estropipate—osteoporosis	0.00114	0.00217	CcSEcCtD
Apomorphine—Fatigue—Zoledronate—osteoporosis	0.00114	0.00216	CcSEcCtD
Apomorphine—Dyspnoea—Conjugated Estrogens—osteoporosis	0.00114	0.00215	CcSEcCtD
Apomorphine—Headache—Calcitriol—osteoporosis	0.00113	0.00215	CcSEcCtD
Apomorphine—Somnolence—Conjugated Estrogens—osteoporosis	0.00113	0.00214	CcSEcCtD
Apomorphine—Constipation—Zoledronate—osteoporosis	0.00113	0.00214	CcSEcCtD
Apomorphine—Nausea—Alendronate—osteoporosis	0.00113	0.00214	CcSEcCtD
Apomorphine—Asthenia—Ethinyl Estradiol—osteoporosis	0.00112	0.00212	CcSEcCtD
Apomorphine—Syncope—Estradiol—osteoporosis	0.00112	0.00212	CcSEcCtD
Apomorphine—Nausea—Raloxifene—osteoporosis	0.00111	0.0021	CcSEcCtD
Apomorphine—Pruritus—Ethinyl Estradiol—osteoporosis	0.00111	0.00209	CcSEcCtD
Apomorphine—Fatigue—Conjugated Estrogens—osteoporosis	0.0011	0.00208	CcSEcCtD
Apomorphine—Nausea—Ibandronate—osteoporosis	0.0011	0.00208	CcSEcCtD
Apomorphine—Loss of consciousness—Estradiol—osteoporosis	0.0011	0.00208	CcSEcCtD
Apomorphine—Asthenia—Risedronate—osteoporosis	0.00109	0.00207	CcSEcCtD
Apomorphine—Feeling abnormal—Zoledronate—osteoporosis	0.00109	0.00206	CcSEcCtD
Apomorphine—Constipation—Conjugated Estrogens—osteoporosis	0.00109	0.00206	CcSEcCtD
Apomorphine—Pruritus—Risedronate—osteoporosis	0.00108	0.00204	CcSEcCtD
Apomorphine—Nausea—Calcitriol—osteoporosis	0.00107	0.00203	CcSEcCtD
Apomorphine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.00107	0.00202	CcSEcCtD
Apomorphine—Chest pain—Estradiol—osteoporosis	0.00106	0.00201	CcSEcCtD
Apomorphine—Arthralgia—Estradiol—osteoporosis	0.00106	0.00201	CcSEcCtD
Apomorphine—Anxiety—Estradiol—osteoporosis	0.00106	0.00201	CcSEcCtD
Apomorphine—Diarrhoea—Risedronate—osteoporosis	0.00104	0.00197	CcSEcCtD
Apomorphine—Asthenia—Pamidronate—osteoporosis	0.00104	0.00197	CcSEcCtD
Apomorphine—Dizziness—Ethinyl Estradiol—osteoporosis	0.00103	0.00196	CcSEcCtD
Apomorphine—Confusional state—Estradiol—osteoporosis	0.00103	0.00195	CcSEcCtD
Apomorphine—Pruritus—Pamidronate—osteoporosis	0.00102	0.00194	CcSEcCtD
Apomorphine—Oedema—Estradiol—osteoporosis	0.00102	0.00193	CcSEcCtD
Apomorphine—Dizziness—Risedronate—osteoporosis	0.00101	0.00191	CcSEcCtD
Apomorphine—Shock—Estradiol—osteoporosis	0.001	0.0019	CcSEcCtD
Apomorphine—Vomiting—Ethinyl Estradiol—osteoporosis	0.000993	0.00188	CcSEcCtD
Apomorphine—Diarrhoea—Pamidronate—osteoporosis	0.000991	0.00188	CcSEcCtD
Apomorphine—Hyperhidrosis—Estradiol—osteoporosis	0.000985	0.00187	CcSEcCtD
Apomorphine—Headache—Ethinyl Estradiol—osteoporosis	0.000979	0.00185	CcSEcCtD
Apomorphine—Vomiting—Risedronate—osteoporosis	0.000968	0.00183	CcSEcCtD
Apomorphine—Dizziness—Pamidronate—osteoporosis	0.000957	0.00181	CcSEcCtD
Apomorphine—Headache—Risedronate—osteoporosis	0.000954	0.00181	CcSEcCtD
Apomorphine—Asthenia—Zoledronate—osteoporosis	0.000949	0.0018	CcSEcCtD
Apomorphine—Pruritus—Zoledronate—osteoporosis	0.000936	0.00177	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000928	0.00176	CcSEcCtD
Apomorphine—Nausea—Ethinyl Estradiol—osteoporosis	0.000928	0.00176	CcSEcCtD
Apomorphine—Insomnia—Estradiol—osteoporosis	0.000922	0.00175	CcSEcCtD
Apomorphine—Vomiting—Pamidronate—osteoporosis	0.000921	0.00174	CcSEcCtD
Apomorphine—Asthenia—Conjugated Estrogens—osteoporosis	0.000914	0.00173	CcSEcCtD
Apomorphine—Dyspnoea—Estradiol—osteoporosis	0.000909	0.00172	CcSEcCtD
Apomorphine—Headache—Pamidronate—osteoporosis	0.000907	0.00172	CcSEcCtD
Apomorphine—Somnolence—Estradiol—osteoporosis	0.000906	0.00172	CcSEcCtD
Apomorphine—Diarrhoea—Zoledronate—osteoporosis	0.000905	0.00171	CcSEcCtD
Apomorphine—Nausea—Risedronate—osteoporosis	0.000905	0.00171	CcSEcCtD
Apomorphine—Pruritus—Conjugated Estrogens—osteoporosis	0.000901	0.00171	CcSEcCtD
Apomorphine—Fatigue—Estradiol—osteoporosis	0.000879	0.00166	CcSEcCtD
Apomorphine—Dizziness—Zoledronate—osteoporosis	0.000874	0.00166	CcSEcCtD
Apomorphine—Constipation—Estradiol—osteoporosis	0.000871	0.00165	CcSEcCtD
Apomorphine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000871	0.00165	CcSEcCtD
Apomorphine—Nausea—Pamidronate—osteoporosis	0.00086	0.00163	CcSEcCtD
Apomorphine—Dizziness—Conjugated Estrogens—osteoporosis	0.000842	0.00159	CcSEcCtD
Apomorphine—Vomiting—Zoledronate—osteoporosis	0.000841	0.00159	CcSEcCtD
Apomorphine—Feeling abnormal—Estradiol—osteoporosis	0.00084	0.00159	CcSEcCtD
Apomorphine—Headache—Zoledronate—osteoporosis	0.000828	0.00157	CcSEcCtD
Apomorphine—Vomiting—Conjugated Estrogens—osteoporosis	0.00081	0.00153	CcSEcCtD
Apomorphine—Headache—Conjugated Estrogens—osteoporosis	0.000798	0.00151	CcSEcCtD
Apomorphine—Nausea—Zoledronate—osteoporosis	0.000786	0.00149	CcSEcCtD
Apomorphine—Nausea—Conjugated Estrogens—osteoporosis	0.000756	0.00143	CcSEcCtD
Apomorphine—Asthenia—Estradiol—osteoporosis	0.000731	0.00138	CcSEcCtD
Apomorphine—Pruritus—Estradiol—osteoporosis	0.000721	0.00137	CcSEcCtD
Apomorphine—Diarrhoea—Estradiol—osteoporosis	0.000697	0.00132	CcSEcCtD
Apomorphine—Dizziness—Estradiol—osteoporosis	0.000674	0.00128	CcSEcCtD
Apomorphine—Vomiting—Estradiol—osteoporosis	0.000648	0.00123	CcSEcCtD
Apomorphine—Headache—Estradiol—osteoporosis	0.000638	0.00121	CcSEcCtD
Apomorphine—Nausea—Estradiol—osteoporosis	0.000605	0.00115	CcSEcCtD
Apomorphine—HTR1B—Signaling Pathways—ADCY5—osteoporosis	4.96e-05	0.000211	CbGpPWpGaD
Apomorphine—ADRA1B—GPCR downstream signaling—POMC—osteoporosis	4.93e-05	0.00021	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—PSMA2—osteoporosis	4.92e-05	0.00021	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—PSMA5—osteoporosis	4.92e-05	0.00021	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—SPP1—osteoporosis	4.9e-05	0.000209	CbGpPWpGaD
Apomorphine—ADRA2B—Hemostasis—TGFB1—osteoporosis	4.89e-05	0.000208	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—ADCY5—osteoporosis	4.88e-05	0.000208	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling by GPCR—POMC—osteoporosis	4.87e-05	0.000207	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—POMC—osteoporosis	4.86e-05	0.000207	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—KL—osteoporosis	4.82e-05	0.000205	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—KL—osteoporosis	4.79e-05	0.000204	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—SPP1—osteoporosis	4.79e-05	0.000204	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling by GPCR—IL6R—osteoporosis	4.75e-05	0.000202	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—IL6R—osteoporosis	4.74e-05	0.000202	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—PTHLH—osteoporosis	4.74e-05	0.000202	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—BMP2—osteoporosis	4.74e-05	0.000202	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—SPP1—osteoporosis	4.72e-05	0.000201	CbGpPWpGaD
Apomorphine—HTR1A—Signaling by GPCR—POMC—osteoporosis	4.7e-05	0.0002	CbGpPWpGaD
Apomorphine—HTR2C—Signaling by GPCR—POMC—osteoporosis	4.68e-05	0.000199	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—IGF1—osteoporosis	4.67e-05	0.000199	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—KL—osteoporosis	4.66e-05	0.000199	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—CALCA—osteoporosis	4.66e-05	0.000199	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—ADCY5—osteoporosis	4.66e-05	0.000198	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—FGB—osteoporosis	4.64e-05	0.000198	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—KL—osteoporosis	4.59e-05	0.000196	CbGpPWpGaD
Apomorphine—HTR1A—Signaling by GPCR—IL6R—osteoporosis	4.59e-05	0.000195	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—CALCA—osteoporosis	4.58e-05	0.000195	CbGpPWpGaD
Apomorphine—ADRA2C—Hemostasis—TGFB1—osteoporosis	4.57e-05	0.000195	CbGpPWpGaD
Apomorphine—HTR2C—Signaling by GPCR—IL6R—osteoporosis	4.56e-05	0.000194	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling by GPCR—POMC—osteoporosis	4.55e-05	0.000194	CbGpPWpGaD
Apomorphine—DRD2—GPCR downstream signaling—POMC—osteoporosis	4.54e-05	0.000194	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—SPP1—osteoporosis	4.5e-05	0.000192	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling by GPCR—POMC—osteoporosis	4.48e-05	0.000191	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—PSMA2—osteoporosis	4.48e-05	0.000191	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—PSMA5—osteoporosis	4.48e-05	0.000191	CbGpPWpGaD
Apomorphine—HTR2A—GPCR downstream signaling—POMC—osteoporosis	4.47e-05	0.000191	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling by GPCR—IL6R—osteoporosis	4.44e-05	0.000189	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—IRS2—osteoporosis	4.43e-05	0.000189	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—ADCY5—osteoporosis	4.39e-05	0.000187	CbGpPWpGaD
Apomorphine—ADRA2C—Metabolism—ADCY5—osteoporosis	4.37e-05	0.000186	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling by GPCR—IL6R—osteoporosis	4.37e-05	0.000186	CbGpPWpGaD
Apomorphine—ADRA2C—Metabolism—GPX1—osteoporosis	4.35e-05	0.000185	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—CYP19A1—osteoporosis	4.34e-05	0.000185	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—IRS2—osteoporosis	4.34e-05	0.000185	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—LEP—osteoporosis	4.33e-05	0.000185	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—ADCY5—osteoporosis	4.33e-05	0.000185	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—ADCY5—osteoporosis	4.33e-05	0.000185	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—IRS2—osteoporosis	4.27e-05	0.000182	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—SPP1—osteoporosis	4.25e-05	0.000181	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—LEP—osteoporosis	4.24e-05	0.000181	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—KL—osteoporosis	4.23e-05	0.00018	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—SPP1—osteoporosis	4.19e-05	0.000179	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—SPP1—osteoporosis	4.19e-05	0.000179	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—LEP—osteoporosis	4.18e-05	0.000178	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—CALCA—osteoporosis	4.17e-05	0.000178	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—KL—osteoporosis	4.16e-05	0.000177	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—ESR1—osteoporosis	4.14e-05	0.000176	CbGpPWpGaD
Apomorphine—DRD2—Signaling by GPCR—POMC—osteoporosis	4.13e-05	0.000176	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—IRS2—osteoporosis	4.07e-05	0.000174	CbGpPWpGaD
Apomorphine—ADRA2A—GPCR downstream signaling—POMC—osteoporosis	4.07e-05	0.000173	CbGpPWpGaD
Apomorphine—HTR2A—Signaling by GPCR—POMC—osteoporosis	4.06e-05	0.000173	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—ESR1—osteoporosis	4.05e-05	0.000173	CbGpPWpGaD
Apomorphine—DRD2—Signaling by GPCR—IL6R—osteoporosis	4.03e-05	0.000172	CbGpPWpGaD
Apomorphine—ADRA2C—Metabolism—MTHFR—osteoporosis	4.02e-05	0.000171	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—ESR1—osteoporosis	3.99e-05	0.00017	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—LEP—osteoporosis	3.99e-05	0.00017	CbGpPWpGaD
Apomorphine—HTR2A—Signaling by GPCR—IL6R—osteoporosis	3.96e-05	0.000169	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—ADCY5—osteoporosis	3.91e-05	0.000167	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—IRS1—osteoporosis	3.87e-05	0.000165	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—IRS2—osteoporosis	3.84e-05	0.000164	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—ESR1—osteoporosis	3.81e-05	0.000162	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—IRS2—osteoporosis	3.79e-05	0.000161	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—IRS2—osteoporosis	3.79e-05	0.000161	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—KL—osteoporosis	3.79e-05	0.000161	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—IRS1—osteoporosis	3.79e-05	0.000161	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—SPP1—osteoporosis	3.78e-05	0.000161	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—ADCY5—osteoporosis	3.77e-05	0.000161	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—LEP—osteoporosis	3.76e-05	0.00016	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—ADCY5—osteoporosis	3.76e-05	0.00016	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—IRS1—osteoporosis	3.72e-05	0.000159	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—POMC—osteoporosis	3.72e-05	0.000159	CbGpPWpGaD
Apomorphine—ADRA2A—Hemostasis—TGFB1—osteoporosis	3.71e-05	0.000158	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—LEP—osteoporosis	3.71e-05	0.000158	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—LEP—osteoporosis	3.71e-05	0.000158	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—POMC—osteoporosis	3.69e-05	0.000157	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—ADCY5—osteoporosis	3.65e-05	0.000156	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—SPP1—osteoporosis	3.65e-05	0.000156	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—POMC—osteoporosis	3.64e-05	0.000155	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—SPP1—osteoporosis	3.63e-05	0.000155	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—IL6R—osteoporosis	3.63e-05	0.000155	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—IL6R—osteoporosis	3.6e-05	0.000154	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—ADCY5—osteoporosis	3.6e-05	0.000153	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—ESR1—osteoporosis	3.59e-05	0.000153	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—POMC—osteoporosis	3.59e-05	0.000153	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—IGF1—osteoporosis	3.58e-05	0.000153	CbGpPWpGaD
Apomorphine—DRD5—Signaling by GPCR—IL6—osteoporosis	3.57e-05	0.000152	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—IL6R—osteoporosis	3.56e-05	0.000151	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—IRS1—osteoporosis	3.56e-05	0.000151	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—ADCY5—osteoporosis	3.55e-05	0.000151	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—ESR1—osteoporosis	3.54e-05	0.000151	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—ESR1—osteoporosis	3.54e-05	0.000151	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—GPX1—osteoporosis	3.54e-05	0.000151	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—SPP1—osteoporosis	3.53e-05	0.000151	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—IGF1—osteoporosis	3.51e-05	0.000149	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—IL6R—osteoporosis	3.5e-05	0.000149	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—SPP1—osteoporosis	3.48e-05	0.000148	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—IGF1—osteoporosis	3.45e-05	0.000147	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—POMC—osteoporosis	3.42e-05	0.000146	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—IRS2—osteoporosis	3.42e-05	0.000146	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—IRS1—osteoporosis	3.35e-05	0.000143	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—LEP—osteoporosis	3.35e-05	0.000143	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—IL6R—osteoporosis	3.34e-05	0.000142	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—ADCY5—osteoporosis	3.31e-05	0.000141	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—IRS1—osteoporosis	3.31e-05	0.000141	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—IRS1—osteoporosis	3.31e-05	0.000141	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—IRS2—osteoporosis	3.3e-05	0.000141	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—IGF1—osteoporosis	3.29e-05	0.00014	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—IRS2—osteoporosis	3.29e-05	0.00014	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—MTHFR—osteoporosis	3.26e-05	0.000139	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—ADCY5—osteoporosis	3.26e-05	0.000139	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—LEP—osteoporosis	3.23e-05	0.000138	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—POMC—osteoporosis	3.23e-05	0.000138	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—LEP—osteoporosis	3.22e-05	0.000137	CbGpPWpGaD
Apomorphine—ADRA2C—Metabolism—POMC—osteoporosis	3.21e-05	0.000137	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—SPP1—osteoporosis	3.21e-05	0.000137	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—ESR1—osteoporosis	3.2e-05	0.000136	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—IRS2—osteoporosis	3.2e-05	0.000136	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—POMC—osteoporosis	3.19e-05	0.000136	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—POMC—osteoporosis	3.19e-05	0.000136	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—SPP1—osteoporosis	3.16e-05	0.000134	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—IL6R—osteoporosis	3.15e-05	0.000134	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—IRS2—osteoporosis	3.15e-05	0.000134	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—LEP—osteoporosis	3.13e-05	0.000133	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—IL6R—osteoporosis	3.11e-05	0.000132	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—IL6R—osteoporosis	3.11e-05	0.000132	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—IGF1—osteoporosis	3.11e-05	0.000132	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—ESR1—osteoporosis	3.09e-05	0.000131	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—LEP—osteoporosis	3.08e-05	0.000131	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—ESR1—osteoporosis	3.07e-05	0.000131	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—IGF1—osteoporosis	3.06e-05	0.000131	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—IGF1—osteoporosis	3.06e-05	0.000131	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—IRS1—osteoporosis	2.99e-05	0.000127	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—ESR1—osteoporosis	2.99e-05	0.000127	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—ADCY5—osteoporosis	2.97e-05	0.000126	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—ESR1—osteoporosis	2.94e-05	0.000125	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—IRS2—osteoporosis	2.9e-05	0.000124	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—IRS1—osteoporosis	2.88e-05	0.000123	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—POMC—osteoporosis	2.88e-05	0.000123	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—SPP1—osteoporosis	2.87e-05	0.000122	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—IRS1—osteoporosis	2.87e-05	0.000122	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—IRS2—osteoporosis	2.85e-05	0.000122	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—LEP—osteoporosis	2.84e-05	0.000121	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—MYC—osteoporosis	2.81e-05	0.00012	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—IL6R—osteoporosis	2.81e-05	0.00012	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—TGFB1—osteoporosis	2.8e-05	0.000119	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—LEP—osteoporosis	2.79e-05	0.000119	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—IRS1—osteoporosis	2.79e-05	0.000119	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—POMC—osteoporosis	2.78e-05	0.000118	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—IGF1—osteoporosis	2.77e-05	0.000118	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—POMC—osteoporosis	2.76e-05	0.000118	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—IRS1—osteoporosis	2.75e-05	0.000117	CbGpPWpGaD
Apomorphine—HTR1D—Signaling by GPCR—IL6—osteoporosis	2.74e-05	0.000117	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—ESR1—osteoporosis	2.71e-05	0.000115	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—IL6R—osteoporosis	2.71e-05	0.000115	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—IL6R—osteoporosis	2.69e-05	0.000115	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—POMC—osteoporosis	2.69e-05	0.000114	CbGpPWpGaD
Apomorphine—HTR1B—Signaling by GPCR—IL6—osteoporosis	2.68e-05	0.000114	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—IGF1—osteoporosis	2.67e-05	0.000114	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—ESR1—osteoporosis	2.67e-05	0.000114	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—IGF1—osteoporosis	2.66e-05	0.000113	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—POMC—osteoporosis	2.64e-05	0.000113	CbGpPWpGaD
Apomorphine—DRD4—Signaling by GPCR—IL6—osteoporosis	2.64e-05	0.000112	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—IL6R—osteoporosis	2.62e-05	0.000112	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—POMC—osteoporosis	2.61e-05	0.000111	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—IRS2—osteoporosis	2.6e-05	0.000111	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—IGF1—osteoporosis	2.58e-05	0.00011	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—IL6R—osteoporosis	2.58e-05	0.00011	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—IGF1—osteoporosis	2.54e-05	0.000108	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—LEP—osteoporosis	2.54e-05	0.000108	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—IRS1—osteoporosis	2.53e-05	0.000108	CbGpPWpGaD
Apomorphine—HTR2B—Signaling by GPCR—IL6—osteoporosis	2.52e-05	0.000107	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—IRS1—osteoporosis	2.49e-05	0.000106	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—POMC—osteoporosis	2.44e-05	0.000104	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—ESR1—osteoporosis	2.43e-05	0.000103	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—POMC—osteoporosis	2.4e-05	0.000102	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—IL6R—osteoporosis	2.38e-05	0.000101	CbGpPWpGaD
Apomorphine—DRD1—Signaling by GPCR—IL6—osteoporosis	2.38e-05	0.000101	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—IGF1—osteoporosis	2.34e-05	9.99e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling by GPCR—IL6—osteoporosis	2.34e-05	9.98e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling by GPCR—IL6—osteoporosis	2.34e-05	9.98e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—IL6R—osteoporosis	2.34e-05	9.97e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—IGF1—osteoporosis	2.31e-05	9.83e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—IRS1—osteoporosis	2.27e-05	9.66e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—POMC—osteoporosis	2.18e-05	9.3e-05	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—MYC—osteoporosis	2.15e-05	9.17e-05	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—TGFB1—osteoporosis	2.15e-05	9.15e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—IL6R—osteoporosis	2.13e-05	9.07e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling by GPCR—IL6—osteoporosis	2.12e-05	9.01e-05	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—IL6—osteoporosis	2.11e-05	9e-05	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—MYC—osteoporosis	2.11e-05	8.98e-05	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—TGFB1—osteoporosis	2.1e-05	8.96e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—IGF1—osteoporosis	2.1e-05	8.94e-05	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—MYC—osteoporosis	2.07e-05	8.83e-05	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—TGFB1—osteoporosis	2.07e-05	8.81e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling by GPCR—IL6—osteoporosis	2.04e-05	8.7e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling by GPCR—IL6—osteoporosis	2.03e-05	8.66e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—MYC—osteoporosis	1.98e-05	8.43e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling by GPCR—IL6—osteoporosis	1.98e-05	8.42e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—TGFB1—osteoporosis	1.97e-05	8.41e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling by GPCR—IL6—osteoporosis	1.95e-05	8.29e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—MYC—osteoporosis	1.87e-05	7.95e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—TGFB1—osteoporosis	1.86e-05	7.93e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—MYC—osteoporosis	1.84e-05	7.85e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—MYC—osteoporosis	1.84e-05	7.85e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—TGFB1—osteoporosis	1.84e-05	7.83e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—TGFB1—osteoporosis	1.84e-05	7.83e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling by GPCR—IL6—osteoporosis	1.79e-05	7.64e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling by GPCR—IL6—osteoporosis	1.76e-05	7.52e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—MYC—osteoporosis	1.66e-05	7.08e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—TGFB1—osteoporosis	1.66e-05	7.07e-05	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—IL6—osteoporosis	1.62e-05	6.89e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—IL6—osteoporosis	1.61e-05	6.84e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—MYC—osteoporosis	1.61e-05	6.84e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—TGFB1—osteoporosis	1.6e-05	6.82e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—MYC—osteoporosis	1.6e-05	6.8e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—TGFB1—osteoporosis	1.59e-05	6.79e-05	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—IL6—osteoporosis	1.58e-05	6.75e-05	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—IL6—osteoporosis	1.56e-05	6.64e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—MYC—osteoporosis	1.55e-05	6.62e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—TGFB1—osteoporosis	1.55e-05	6.6e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—MYC—osteoporosis	1.53e-05	6.51e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—TGFB1—osteoporosis	1.52e-05	6.5e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—IL6—osteoporosis	1.49e-05	6.34e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—MYC—osteoporosis	1.41e-05	6e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—TGFB1—osteoporosis	1.41e-05	5.99e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—IL6—osteoporosis	1.4e-05	5.98e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—MYC—osteoporosis	1.39e-05	5.91e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—IL6—osteoporosis	1.38e-05	5.9e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—IL6—osteoporosis	1.38e-05	5.9e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—TGFB1—osteoporosis	1.38e-05	5.89e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—MYC—osteoporosis	1.26e-05	5.37e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—TGFB1—osteoporosis	1.26e-05	5.36e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—IL6—osteoporosis	1.25e-05	5.33e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—IL6—osteoporosis	1.21e-05	5.14e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—IL6—osteoporosis	1.2e-05	5.11e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—IL6—osteoporosis	1.17e-05	4.97e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—IL6—osteoporosis	1.15e-05	4.9e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—IL6—osteoporosis	1.06e-05	4.51e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—IL6—osteoporosis	1.04e-05	4.44e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—IL6—osteoporosis	9.48e-06	4.04e-05	CbGpPWpGaD
